Verve Therapeutics Inc (VERV)
5.00
+0.28
(+5.93%)
USD |
NASDAQ |
Oct 04, 16:00
5.00
0.00 (0.00%)
After-Hours: 20:00
Verve Therapeutics Shareholders Equity (Annual): 599.50M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 599.50M |
| December 31, 2022 | 550.93M |
| December 31, 2021 | 357.35M |
| Date | Value |
|---|---|
| December 31, 2020 | -63.91M |
| December 31, 2019 | -19.55M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-63.91M
Minimum
2020
599.50M
Maximum
2023
284.86M
Average
357.35M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Ardelyx Inc | 166.82M |
| Biomarin Pharmaceutical Inc | 4.952B |
| Neurocrine Biosciences Inc | 2.232B |
| ALX Oncology Holdings Inc | 189.71M |
| Immuneering Corp | 90.58M |